121 Best Deep Tech Startups to Watch in 2023

121 Deep Tech Startups to Watch (and Work for) in 2023

Deep Tech's tech sector is booming. This year’s list of the best 121 Deep Tech tech startups is an eclectic mix of hyper-growth scaleups, small creative startups and everything in between.

Curated by @gonsanchezs

Deep Tech 10+ employees Fast-growing

The last update was made on March 14, 2023.


Get smarter about European tech

Join 21,000+ subscribers receiving a 5-minute update on European tech every Sunday.


Get the full list of 9,200+ European tech companies

Download a carefully-curated .csv of over 9,200+ fast-growing European tech companies you can research, apply to and do business with.

Learn more
Precirix

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

Brussels   11 to 50   $130 Million   $88 Million  

Novo A/S   Forbion Capital Partners   Gimv   HealthCap   Inkef Capital   V-Bio Ventures   BioMedPartners  

B2B  

Splice Bio

Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University.

Barcelona   11 to 50   $59 Million   $57 Million  

New Enterprise Associates   Asabys Partners   Ysios Capital   UCB Ventures   Novartis Venture Fund  

B2B  

LabGenius

LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.

London   51 to 100   $29 Million   $25 Million  

Atomico   Kindred Capital  

B2B  

Automata

Automata is a biotechnology company that provides workflow automation for the life sciences industry.

London   11 to 50   $60 Million   $7.4 Million  

Local Globe   Hummingbird Ventures   Entrepreneur First   Octopus Ventures   HCVC   Latitude   Firstminute Capital   Isomer Capital   Aldea VC  

B2B  

Automata

Automata is a biotechnology company that provides workflow automation for the life sciences industry.

London   11 to 50   $60 Million   $7.4 Million  

Local Globe   Hummingbird Ventures   Entrepreneur First   Octopus Ventures   HCVC   Latitude   Firstminute Capital   Isomer Capital   Aldea VC  

B2B  

Leyden Labs

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam   11 to 50   $190 Million   $48 Million  

SoftBank Group   GV  

B2B  

Carrick Therapeutics

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Dublin   51 to 100   $95 Million   $60 Million  

GV   Cambridge Innovation Capital  

Volocopter

Volocopter is an urban air mobility service provider that builds electric air taxis.

Munich   11 to 50   $130 Million   $55 Million  

btov Partners  

B2B  

Tubulis

Tubulis Technologies generates uniquely matched protein-drug conjugates.

Munich   11 to 50   $77 Million   $12 Million  

High-Tech Gründerfonds   Coparion   Bayern Kapital   BioMedPartners   Seventure Partners   Andera Partners  

B2B  

ImCheck Therapeutics

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

Marseille   11 to 50   $190 Million   $100 Million  

Earlybird Venture Capital   Eurazeo   Andera Partners   Gimv  

B2B  

Mavenoid

Mavenoid's AI-powered platform allows hardware & consumer electronics companies to provide seamless support automation and remote service.

Stockholm   51 to 100   $9.9 Million   $8 Million  

Creandum   Point Nine Capital   Mosaic Ventures   NordicNinja VC   Smedvig Capital  

B2B   SAAS  

7bridges

7bridges is an AI-powered optimization engine for businesses to scale and automate logistics and supply chains.

London   11 to 50   $3.4 Million   $3.4 Million  

Local Globe   Crane Venture Partners   Eight Roads Ventures  

B2B   SAAS  

Flexciton

Flexciton is the intelligent advantage platform for streamlined chipmaking

London   11 to 50   $29 Million   $3.2 Million  

BACKED VC   Entrepreneur First   Join Capital  

B2B  

Dixa

Dixa is a conversational customer engagement software that connects brands with customers through real-time communication.

Copenhagen   101 to 250   $160 Million   $14 Million  

Project A Ventures   Notion Capital   Seed Capital  

B2B   SAAS  

Cognite

Cognite develops an industrial IoT data platform that enables digital transformation of heavy-asset industries.

Oslo   501 to 1000   $340 Million   $8.7 Million  

Accel  

B2B   SAAS  

Karakuri

Karakuri is revolutionising Quick Service (QSR) and Fast Casual restaurants with intelligent, robotic kitchen automation.

London   11 to 50   $18 Million   $8.5 Million  

Hoxton Ventures   Firstminute Capital  

B2B  

BotsAndUs

BotsAndUs captures real-time insights of warehouse operations using fully autonomous robots and Artificial Intelligence.

London   11 to 50   $19 Million   $6 Million  

Kindred Capital   Lakestar   Capnamic Ventures  

B2C   SAAS  

Elypta

Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring

Stockholm   11 to 50   $33 Million   $6.7 Million  

Nina Capital   Norrsken VC   Industrifonden   Bonnier Ventures   Navigare Ventures  

B2B  

Core Biogenesis

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

Paris   1 to 10   $25 Million   $3.2 Million  

Entrepreneur First   Plug and Play Spain   XAnge   Thia Ventures  

B2B  

Gourmey

We create sustainable cultivated meat delights for an uncompromising and conscious generation.

Paris   11 to 50   $58 Million   $200 Thousand  

Earlybird Venture Capital   Heartcore   Point Nine Capital   Air Street Capital   Partech Ventures   Keen Venture Partners   Social Starts   Thia Ventures  

B2B   B2C  

Tropic Biosciences

Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.

London   11 to 50   $39 Million   $29 Million  

Future Planet Capital  

B2B  

CMR Surgical

CMR Surgical is developing the next-generation surgical robotic system for minimal access surgery.

Cambridge   251 to 500   $970 Million   $240 Million  

SoftBank Group   Lightrock   Cambridge Innovation Capital  

B2B  

Exotec

Exotec offers an innovative order preparation system, based on a fleet of collaborative mobile robots.

Lille   251 to 500   $450 Million   $90 Million  

83North   Goldman Sachs   Breega Capital  

B2B  

Puraffinity

Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water

London   11 to 50   $7.4 Million   $3.6 Million  

Kindred Capital   Verve Ventures  

B2B  

Arculus

Arculus helps multi-variant manufacturers cope with the market's bespoke customisation demand, being more efficient and cost-effective.

Munich   101 to 250   $21 Million   $3 Million  

Atomico   La Famiglia VC   Visionaries Club  

B2B   SAAS  

Brytlyt

Brytlyt is a young and dynamic company with a clear mission – to empower organisations through transformational data analytics.

London   11 to 50   $6 Million   $4 Million  

Finch Capital   AlbionVC   Amadeus Capital  

B2B   SAAS  

Slamcore

SLAMcore provides location, mapping and perception software for robots and other autonomous machines to become spatially intelligent

London   11 to 50   $27 Million   $5 Million  

Octopus Ventures   MMC Ventures   Amadeus Capital  

B2B   SAAS  

Wandelbots

Wandelbots is a technology platform that enables non-programmers to train industrial robots to complete precision tasks.

Dresden   11 to 50   $38 Million   $30 Million  

83North   EQT Ventures   Insight Venture Partners   Atlantic Labs   Paua Ventures  

B2B   SAAS  

Elsa

Elsa is a platform for patient-driven research for better drugs, health, and prevention.

Stockholm   11 to 50   $8 Million   $2.3 Million  

Inventure   Norrsken VC   HealthCap  

MARKETPLACE  

Greenely

Greenely is a digital energy provider, creating the most compelling experience around your electricity usage

Stockholm   11 to 50   $5.6 Million   $2.7 Million  

Luminar Ventures   byFounders  

B2C  

Bolk

Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.

Paris   11 to 50   $4.6 Million   $4.5 Million  

Kima Ventures  

B2B   B2C  

ieso

Transforming mental healthcare by unlocking the power of clinical data

Cambridge   101 to 250   $78 Million   $53 Million  

Molten Ventures  

B2B   B2C  

Enterome

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

Paris   51 to 100   $150 Million   $52 Million  

Seventure Partners  

B2B  

Baseimmune

Baseimmune is a biotech startup founded to create the next generation of vaccines.

London   1 to 10   $5.7 Million   $950 Thousand  

Hoxton Ventures   Cherry Ventures   Maki.vc   Creator Fund  

B2B  

HiFiBiO

HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.

Paris   101 to 250   $180 Million   $75 Million  

Foodsteps

Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint.

London   11 to 50   $4.8 Million   $4.1 Million  

Ascension Ventures   Octopus Ventures   Metaplanet Holdings  

B2B   SAAS  

SparingVision

SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.

Paris   1 to 10   $53 Million   $53 Million  

Ysios Capital  

B2B  

InnovaFeed

InnovaFeed is a biotech company producing insect-based protein for the feed industry.

Paris   101 to 250   $230 Million   $250 Million  

Arrival

Arrival is a developer and manufacturer of zero-emission, public transportation vehicles.

London   1001 to 5000   $630 Million   $110 Million  

B2B  

Kewazo

KEWAZO is digitizing construction with robotics and data analytics

Munich   11 to 50   $9.1 Million   $2.8 Million  

True Ventures  

B2B  

WeMaintain

WeMaintain is the first B2B platform linking skilled technicians and professional customers.

Paris   11 to 50   $10 Million   $7.9 Million  

Eurazeo  

B2B   SAAS  

IOmx Therapeutics

iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics.

Munich   11 to 50   $120 Million   $75 Million  

Coave Therapeutics

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Paris   11 to 50   $92 Million   $39 Million  

V-Bio Ventures   Seroba Life Sciences  

B2B  

MiNA Therapeutics

MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms.

London   11 to 50   $90 Million   $30 Million  

B2B  

Wandercraft

Wandercraft develops and sells the first exoskeleton to walk self-balanced, for inpatient rehab and outpatient daily life.

Paris   51 to 100   $76 Million   $45 Million  

XAnge  

B2B  

GH Research

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Dublin   1 to 10   $130 Million   $130 Million  

Minoryx Therapeutics

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

Barcelona   11 to 50   $140 Million   $55 Million  

Alira Health

Alira Health is an international advisory firm.

Paris   101 to 250   $75 Million   $35 Million  

The Mobility House

The Mobility House enables the integration of vehicle batteries into the power grid via intelligent charging, energy, and storage solutions.

Munich   101 to 250   $51 Million  

Alliance  

B2B  

Photoneo

Photoneo is a developer of industrial 3D vision cameras along with AI-powered automation solutions and robotic intelligence software.

Bratislava   101 to 250   $2.4 Million   $21 Million  

Earlybird Venture Capital  

B2B   SAAS  

Epsilogen

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

London   11 to 50   $53 Million   $42 Million  

Novartis Venture Fund  

B2B  

Smartex.ai

Smartex.ai is an AI and computer vision company that uses automated inspection to detect textile defects.

Porto   51 to 100   $0   $25 Million  

Lightspeed Venture Partners  

Supplant

Supplant is a biotechnology platform that makes sugar substitutes.

Cambridge   11 to 50   $42 Million   $24 Million  

Khosla Ventures   Y Combinator   Felicis Ventures  

B2B  

LUMICKS

LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.

Amsterdam   51 to 100   $93 Million   $93 Million  

DNA Script

DNA Script is focused on the manufacturing of synthetic DNA using a proprietary template-free enzymatic technology.

Paris   11 to 50   $63 Million   $50 Million  

B2B  

IO Biotech

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Copenhagen   11 to 50   $180 Million   $8.8 Million  

Novo A/S   EIR Ventures  

B2B  

Exogene

Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening.

London   1 to 10   $2.1 Million   $100 Thousand  

Atomico   Entrepreneur First  

B2B  

Myricx Pharma

Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.

London   1 to 10   $5.9 Million   $6 Million  

Sofinnova Partners  

B2B  

Alice & Bob

Alice&Bob build Universal, Error-free, Quantum Computers to help industries and researchers solve the hardest problems.

Paris   1 to 10   $3.3 Million   $30 Million  

Outsight

Outsight develops a revolutionary kind of sensor, a 3D Semantic Camera that brings Full Situation Awareness to Smart Machines and Cities.

Paris   11 to 50   $42 Million   $20 Million  

Demeter Partners  

B2B  

Wisear

Wisear enables people to get high-speed, private & inclusive controls over their everyday devices

Paris   11 to 50   $1.4 Million   $120 Thousand  

Kima Ventures  

B2B  

TTTech Auto

TTTech Auto specializes in safe software platforms for automated driving and beyond, applicable in series production programs.

Vienna   1001 to 5000   $290 Million   $290 Million  

B2B  

BonBot

BonBot is a Food & Beverages company.

Stockholm     $2.4 Million   $2.4 Million  

Stride VC   byFounders  

B2B  

Atai Life Sciences

ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.

Munich   101 to 250   $520 Million   $45 Million  

B2B  

Scenic Biotech

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.

Amsterdam   11 to 50   $42 Million   $31 Million  

Inkef Capital   Vesalius Biocapital Partners   EIR Ventures   Oxford Science Enterprises   BioMedPartners  

B2B  

Mindstep

Mindstep towards better better brain health.

London   11 to 50   $3.9 Million   $450 Thousand  

Octopus Ventures   Calm/Storm Ventures  

B2B   B2C  

Oncopeptides

Oncopeptides AB is a privately held clinical stage company developing melflufen, a peptidase potentiated therapy for multiple myeloma.

Stockholm   251 to 500   $210 Million   $31 Million  

European Investment Bank  

Moon Surgical

Moon Surgical aims to augment the surgeons with leaps forward in computer vision, haptics, and robotics in its proprietary platform

Paris   1 to 10   $37 Million   $3.4 Million  

Sofinnova Partners  

B2B  

Phenix

PHENIX is a web and service platform specialized in the reduction of waste.

Paris   51 to 100   $17 Million   $14 Million  

ETF Partners  

B2B  

Nomagic

Nomagic provides smart pick and place robotic solutions for order fulfillment.

Warsaw   11 to 50   $8.6 Million   $8.6 Million  

Hoxton Ventures   Khosla Ventures   Almaz Capital   Capnamic Ventures   DN Capital  

B2B  

Climeworks

Climeworks engages in capturing CO2 from the air via commercial carbon dioxide removal technology.

Zürich   101 to 250   $780 Million   $110 Million  

Global Founders Capital (GFC)   GIC  

B2B  

Sophia Genetics

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Boston   251 to 500   $250 Million   $110 Million  

Eurazeo   Swisscom Ventures  

B2B  

INERATEC

INERATEC provides sustainable fuels, gas-to-liquid, power-to-gas and power-to-liquid application products.

Karlsruhe   101 to 250   $23 Million   $20 Million  

High-Tech Gründerfonds   Planet A Ventures   Extantia Capital  

B2B  

Agile Analog

Agile Analog is a company with a mission to transform the landscape of the Analog IP market space.

Cambridge   11 to 50   $24 Million   $5 Million  

Omers Ventures   Firstminute Capital   MMC Ventures  

B2B  

ONI

ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.

Oxford   51 to 100   $110 Million   $75 Million  

Axon Ventures   Oxford Science Enterprises  

B2B  

Keelvar

Keelvar offers advanced sourcing optimization and intelligent sourcing automation software.

Cork   101 to 250   $43 Million   $18 Million  

83North   Mosaic Ventures   Paua Ventures  

B2B   SAAS  

Samotics

Samotics is a predictive maintenance system for AC motors and rotating equipment.

The Hague   51 to 100   $33 Million   $7.1 Million  

83North  

B2B   SAAS  

GFBiochemicals

GFBiochemicals company to produce levulinic acid at commercial scale directly from biomass.

Milan   11 to 50   $16 Million   $16 Million  

Sofinnova Partners  

B2B  

Mestag Therapeutics

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Cambridge   1 to 10   $11 Million   $11 Million  

GV   Forbion Capital Partners  

B2B  

Sensat

SenSat simulates reality in real time, which helps computers solve real world problems.

London   51 to 100   $15 Million   $10 Million  

B2B   SAAS  

OptiNose

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

Oslo   101 to 250   $400 Million   $50 Million  

Synthace

Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.

London   11 to 50   $81 Million  

Sofinnova Partners  

B2B   SAAS  

Tekyn

Tekyn is a designer and manufacturer of on demand fashion textiles.

Paris   11 to 50   $6.5 Million   $4 Million  

Otium Capital  

B2B  

Kitman Labs

Kitman Labs is a sports analytics platform that generates insights to help professional athletes perform better.

Dublin   101 to 250   $76 Million   $5.1 Million  

B2B   SAAS  

Synthace

Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.

London   11 to 50   $81 Million  

Sofinnova Partners  

B2B   SAAS  

Medlumics

Medlumics is a startup employing biophotonic technologies to develop products that improve human living standards.

Madrid   11 to 50   $69 Million   $16 Million  

Andera Partners   Asabys Partners   Caixa Capital Risc  

B2B  

Nuclera

Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.

Cambridge   11 to 50   $69 Million   $43 Million  

Verve Ventures   Future Planet Capital   Amadeus Capital  

B2B  

Seyo

Seyo is the trading name of Seyo Limited a company registered (Company Number: 11701852) in England and Wales.

London   1 to 10   $2.6 Million  

Entrepreneur First   Ascension Ventures   Plug and Play Spain   7percent Ventures  

B2B   SAAS  

MiroBio

MiroBio is Harnessing the natural control mechanisms of the immune system.

Oxford   1 to 10   $130 Million   $97 Million  

Medicxi   Oxford Science Enterprises  

B2B  

Microbiotica

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Cambridge   11 to 50   $83 Million   $67 Million  

Seventure Partners   Cambridge Innovation Capital  

B2B  

DeepScenario

DeepScenario provides real-world traffic data with high accuracy to help companies build the world’s most intelligent driver.

Munich   1 to 10   $0  

High-Tech Gründerfonds   MobilityFund  

B2B   SAAS  

Polymateria

Polymateria is a London-based startup advancing science to help nature deal with plastic pollution.

London   11 to 50   $19 Million   $19 Million  

B2B  

Enchanted Tools

Enchanted Tools is the marvelous way to enchant Robotics with the use of Mechatronics, Artificial Intelligence, Robotics and Animation Tech.

Paris   11 to 50   $0   $17 Million  

B2B  

Femtogenix

Femtogenix is develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates.

  11 to 50   $0   $68 Million  

B2B  

Ganymed Robotics

Ganymed Robotics develops smart robots for orthopedic surgery.

Paris   11 to 50   $24 Million   $2.2 Million  

B2B  

Humanising Autonomy

Humanising Autonomy is building the global standard for human machine interactions.

London   11 to 50   $17 Million   $5.3 Million  

Anthemis  

B2B  

Sarcura

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

Tulln   11 to 50   $10 Million   $3 Million  

HCVC   Nina Capital  

B2B   SAAS  

Cubiq Foods

CUBIQ FOODS is a ealthy cell-based fats company.

Barcelona   11 to 50   $16 Million   $15 Million  

B2B  

Piclo

Piclo develop software to make our electricity grids smart, flexible and sustainable.

London   11 to 50   $11 Million   $6.6 Million  

B2B   MARKETPLACE  

Veritas Intercontinental

Genetics.The mission of Veritas Int. is to fulfill the promise of the human genome, empowering people to maximize quality and length of life

Madrid   11 to 50   $26 Million   $5.9 Million  

Amadeus Capital  

B2B  

Magazino

Magazino develops mobile, perception driven robots for warehouse logistics and intralogistics.

Munich   11 to 50   $49 Million   $10 Million  

B2B  

Perfect Ward

Perfect Ward is the health and quality inspection solution.

London   11 to 50   $5.6 Million   $5.5 Million  

octopus investments  

B2B   SAAS  

QUIBIM

Quibim, a company with its headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis.

Valencia   51 to 100   $20 Million   $9.3 Million  

Atomico   Partech Ventures   Adara Ventures   Amadeus Capital  

B2B   SAAS  

HMNC Brain Health

HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.

Munich   11 to 50   $38 Million   $11 Million  

ALSTIN Capital  

B2B  

Translated

Professional translation services made easy. Crafted by expert humans, powered by technology, efficiently delivered.

Rome   101 to 250   $30 Million   $30 Million  

B2B   SAAS  

Magazino

Magazino develops mobile, perception driven robots for warehouse logistics and intralogistics.

Munich   11 to 50   $49 Million   $10 Million  

B2B  

Rappta Therapeutics

Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.

Helsinki   1 to 10   $11 Million   $11 Million  

Novo A/S   Novartis Venture Fund  

B2B  

Canatu

Canatu develops and manufactures innovative 3D formable and stretchable films and sensors for 3D touch surfaces and heater solutions.

Helsinki   51 to 100   $70 Million   $17 Million  

B2B  

Deciphex

Deciphex uses digital pathology and AI to address the pathology productivity gap

Dublin   51 to 100   $20 Million   $6.2 Million  

Act Venture Capital   Novartis Venture Fund  

B2B   SAAS  

cylib

Cylib is a start-up for holistic battery recycling

Aachen   1 to 10   $3.5 Million   $3.5 Million  

Speedinvest   Blue Impact Ventures   Vsquared Ventures  

B2B  

Kambr

Raising airline revenue performance through Software, Consultancy and Content.

Amsterdam   11 to 50   $7 Million   $4 Million  

Global Founders Capital (GFC)  

B2B   SAAS  

EasyMile

EasyMile is a high-tech startup specialized in providing both, software powering autonomous vehicles and smart mobility solutions.

Toulouse   101 to 250   $91 Million   $67 Million  

B2B   SAAS  

MindMaze

MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat and rehab patients.

Lausanne   101 to 250   $340 Million   $130 Million  

Hambro Perks Ltd.  

B2B  

ecoRobotix

ecoRobotix offers machinery and agriculture.

Lausanne   101 to 250   $28 Million   $15 Million  

Verve Ventures   Swisscom Ventures   Capagro  

B2B  

Oculis

Oculis is a clinical-stage, privately held, pharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

Reykjavík   11 to 50   $94 Million   $57 Million  

Sotio

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

Prague   251 to 500   $320 Million   $320 Million  

Distalmotion

DistalMotion develops medical devices that are used to perform minimal-invasive surgeries.

Lausanne   1 to 10   $250 Thousand   $90 Million  

B2B  

Touchlight

TouchLight Innovations provides distributed generation solutions, enabling commercial property owners self-generate electricity on-site.

Brooklyn   1 to 10   $330 Thousand   $130 Million  

B2B  

Artios Pharma

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

Cambridge   101 to 250   $300 Million   $150 Million  

Pharvaris

Pharvaris is a clinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients.

Zug   11 to 50   $160 Million   $80 Million  

B2B  

Osler Diagnostics

Lab-quality diagnostics for anyone, anywhere, at any time.

Oxford   51 to 100   $180 Million   $46 Million  

Oxford Science Enterprises  

B2B  

Get the full list of 9,200+ Deep Tech & European tech companies

Download a carefully-curated .csv of over 9,200+ fast-growing European tech companies you can research, apply to and do business with.

  • 🏢 Company
  • 📊 Industry
  • 🌎 Location
  • 💰 Money Raised
  • 🔗 URL
  • 💼 Linkedin URL
  • 👤 Company Size
  • ➕ and more
Download for €49

⚠️ Price goes up to €99 on March 28

SOME OF OUR CLIENTS

  • Company
  • Hopin
  • Glovo
  • N26
  • Curve
  • Pipedrive
  • TIER
  • Industry
  • Events
  • Food
  • Fintech
  • Fintech
  • Sales
  • Mobility
  • Location
  • London
  • Barcelona
  • Berlin
  • London
  • Tallinn
  • Berlin
  • Raise
  • $125M
  • $169M
  • $100M
  • $59M
  • $500M
  • $250M
  • URL
  • hopin.com
  • glovo.com
  • n26.com
  • curve.com
  • pipedrive.com
  • tier.app

Explore other top startups & industries across Europe

...
Femtech Trends ♀️

The term femtech was coined by European entrepreneur Ida Tin in 2016 so it’s only natural to explore it.

...
London Startups

Forget all about Brexit. Europe's tech capital is still booming with fintech at its core.

...
Berlin Startups

In Berlin, a new startup is founded every 20 minutes. What else is there to say?